Key Details
Price
$2.70Annual ROE
-58.48%Beta
1.26Events Calendar
Next earnings date:
Mar 11, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
Mar 11, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Jan 21, 25 RBC Capital
OutperformNov 14, 24 HC Wainwright & Co.
BuyNov 13, 24 Leerink Partners
OutperformNov 13, 24 Chardan Capital
BuyOct 31, 24 HC Wainwright & Co.
BuyOct 30, 24 Chardan Capital
BuyOct 25, 24 Chardan Capital
BuyAug 14, 24 Chardan Capital
BuyAug 13, 24 RBC Capital
OutperformAug 13, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Lexeo Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Lexeo Therapeutics?
- Does Lexeo Therapeutics pay dividends?
- What sector is Lexeo Therapeutics in?
- What industry is Lexeo Therapeutics in?
- What country is Lexeo Therapeutics based in?
- When did Lexeo Therapeutics go public?
- Is Lexeo Therapeutics in the S&P 500?
- Is Lexeo Therapeutics in the NASDAQ 100?
- Is Lexeo Therapeutics in the Dow Jones?
- When was Lexeo Therapeutics's last earnings report?
- When does Lexeo Therapeutics report earnings?
- Should I buy Lexeo Therapeutics stock now?
What is the ticker symbol for Lexeo Therapeutics?
The ticker symbol for Lexeo Therapeutics is NASDAQ:LXEO
Does Lexeo Therapeutics pay dividends?
No, Lexeo Therapeutics does not pay dividends
What sector is Lexeo Therapeutics in?
Lexeo Therapeutics is in the Healthcare sector
What industry is Lexeo Therapeutics in?
Lexeo Therapeutics is in the Biotechnology industry
What country is Lexeo Therapeutics based in?
Lexeo Therapeutics is headquartered in United States
When did Lexeo Therapeutics go public?
Lexeo Therapeutics's initial public offering (IPO) was on November 3, 2023
Is Lexeo Therapeutics in the S&P 500?
No, Lexeo Therapeutics is not included in the S&P 500 index
Is Lexeo Therapeutics in the NASDAQ 100?
No, Lexeo Therapeutics is not included in the NASDAQ 100 index
Is Lexeo Therapeutics in the Dow Jones?
No, Lexeo Therapeutics is not included in the Dow Jones index
When was Lexeo Therapeutics's last earnings report?
Lexeo Therapeutics's most recent earnings report was on Nov 13, 2024
When does Lexeo Therapeutics report earnings?
The next expected earnings date for Lexeo Therapeutics is Mar 11, 2025
Should I buy Lexeo Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions